These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 13723491)

  • 1. [Sanamycin--observations and critical considerations].
    DOKTORCZYK H
    Pol Tyg Lek; 1960 Dec; 15():1971-3. PubMed ID: 13723491
    [No Abstract]   [Full Text] [Related]  

  • 2. [Sanamycin (actinomycin C) in the treatment of malignant tumors and lymphogranulomatosis].
    SCHMIDT H; LOOSEN H; HEINEN W
    Dtsch Med Wochenschr; 1955 Jan; 80(4):140-3. PubMed ID: 14352774
    [No Abstract]   [Full Text] [Related]  

  • 3. Polyneuritis in lymphogranulomatosis treated with actinomycin C (sanamycin).
    MUHLER E
    Medizinische; 1959 Mar; 4(10):423-5. PubMed ID: 13643492
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical experience with actinomycin C.
    BEGEMANN H
    Ann N Y Acad Sci; 1960 Oct; 89():454-62. PubMed ID: 13688656
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of lympho granulomatosis with sanamycin.
    NITSCH W; THEIN K
    Ther Ggw; 1955 Feb; 94(2):49-51. PubMed ID: 14373641
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical experience with sanamycin in lymphogranulomatosis.
    OSTEN W; ZADEMACK
    Medizinische; 1955 Apr; 18():687-9. PubMed ID: 14383134
    [No Abstract]   [Full Text] [Related]  

  • 7. [Case of malignant granuloma treated with sanamycin].
    MOKRZYCKI M
    Pol Tyg Lek (Wars); 1957 Oct; 12(41):1581-4. PubMed ID: 13505274
    [No Abstract]   [Full Text] [Related]  

  • 8. [Electrophoretic blood tests in lymphogranulomatosis treated with sanamycin].
    HAENSCH R
    Z Haut Geschlechtskr; 1956 Nov; 21(10):269-72. PubMed ID: 13401934
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experiences with sanamycin].
    ECKHARDT S; HARTAI F; MOLNAR E
    Orv Hetil; 1955 Oct; 96(42):1168-9. PubMed ID: 13289063
    [No Abstract]   [Full Text] [Related]  

  • 10. [EVALUATION OF THE CURRENT THERAPEUTIC TRENDS IN HODGKIN'S DISEASE. CRITICAL REVIEW AND CASUISTIC CONTRIBUTION].
    TAGLIORETTI D; TESTERO S; TISO R; ERIDANI S
    Arch Patol Clin Med; 1963 Aug; 40():3-32. PubMed ID: 14058830
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy of Hodgkin disease and non-Hodgkin lymphomas].
    Sréter L
    Orv Hetil; 2003 Dec; 144(49):2429-31. PubMed ID: 14725211
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical and biologic studies of actinomycin D and roentgen irradiation.
    D'ANGIO GJ
    Am J Roentgenol Radium Ther Nucl Med; 1962 Jan; 87():106-9. PubMed ID: 13882969
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of actinomycin D on cancer in childhood.
    TAN CT; DARGEON HW; BURCHENAL JH
    Pediatrics; 1959 Oct; 24():544-61. PubMed ID: 13836792
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical studies of actinomycin D.
    WATNE AL; BADILLO J; KOIKE A; KONDO T; MOORE GE
    Ann N Y Acad Sci; 1960 Oct; 89():445-53. PubMed ID: 13783411
    [No Abstract]   [Full Text] [Related]  

  • 15. The clinical applications and methods of administration of actinomycin in the treatment of different tumors.
    RAVINA A; PESTEL M
    Ann N Y Acad Sci; 1960 Oct; 89():463-73. PubMed ID: 13739900
    [No Abstract]   [Full Text] [Related]  

  • 16. Ifosfamide, idarubicin, and etoposide in relapsed/refractory Hodgkin disease or non-Hodgkin lymphoma: a salvage regimen with high response rates before autologous stem cell transplantation.
    Oyan B; Koc Y; Ozdemir E; Kars A; Turker A; Tekuzman G; Kansu E
    Biol Blood Marrow Transplant; 2005 Sep; 11(9):688-97. PubMed ID: 16125639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experiences with actinomycin D in the treatment of malignant disease in children.
    COLEBATCH JH
    Med J Aust; 1960 Nov; 47(2)():804-7. PubMed ID: 13694587
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of actinomycin D on childhood neoplasms.
    SHAW RK; MOORE EW; MUELLER PS; FREI E; WATKIN DM
    AMA J Dis Child; 1960 May; 99():628-35. PubMed ID: 14445656
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognostic factors in children with Hodgkin disease.
    Celkan T; Yildiz I
    Pediatr Blood Cancer; 2008 Nov; 51(5):712; author reply 712-3. PubMed ID: 18668513
    [No Abstract]   [Full Text] [Related]  

  • 20. Hodgkin lymphoma with leptomeningeal involvement.
    Malhotra P; Jain S; Nath A; Rajwanshi A; Jain S; Kumari S; Varma S
    Am J Hematol; 2006 Feb; 81(2):153-4. PubMed ID: 16432871
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.